Brian Kennedy Ph.D.

National University of Singapore - Director of the Centre for Healthy Longevity

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of delaying, detecting, and preventing human aging and associated diseases. He is a Professor in the Departments of Biochemistry and Physiology at National University Singapore and Director of the Centre for Healthy Ageing in the National University Health System. From 2010 to 2016 he was the President and CEO of the Buck Institute for Research on Aging. Currently, he remains as a Professor at the Institute. Dr. Kennedy also has an adjunct appointment at the USC Davis School of Gerontology. Dr. Kennedy is also actively involved Biotechnology companies, serving in consulting and Board capacities, as well as Scientific Director of Affirmativ Health. Dr. Kennedy also serves as a Co-Editor-In-Chief at Aging Cell.

Hanadie Yousef, Ph.D.

Juvena Therapeutics - CEO and Co-founder

Dr. Hanadie Yousef is a neurobiologist, stem cell biologist and entrepreneur leading Juvena Therapeutics in its mission to develop protein-based therapeutics to promote tissue regeneration and increase healthspan in the elderly. Dr. Yousef’s ground-breaking research over the last 17 years has been supported by multiple fellowships and grants leading to numerous issued and pending patents and high-profile publications on mechanisms of aging and methods for tissue rejuvenation. Her key discoveries laid the foundation of Juvena Therapeutics’ venture-backed, drug discovery and preclinical development platform. Dr. Yousef earned a BS in Chemistry from Carnegie Mellon University, a PhD in Molecular and Cell Biology from UC Berkeley, pursued a 5-year postdoctoral fellowship in Neurology at Stanford School of Medicine and conducted R&D at Regeneron and Genentech.

Vadim Gladyshev, Ph.D.

Harvard Medical School - Professor of Medicine

Dr. Vadim Gladyshev is a Professor of Medicine at Brigham and Women’s Hospital, Harvard Medical School, and an Associate Member of the Broad Institute. He is also Director of the Center for Redox Medicine. Dr. Gladyshev’s lab applies high-throughput and computational approaches to understand the mechanisms of aging, control of lifespan, and the redox regulation of cellular processes. His lab recently developed biomarkers of mouse aging based on blood DNA methylation patterns. Dr. Gladyshev has published approximately 300 articles and has been elected as an AAAS fellow. He is a 2013 recipient of the NIH Director’s Pioneer Award to study the mechanisms of longevity.

Matthew O'Connor

Cyclarity Therapeutics - CEO of Science Affairs

Dr. O'Connor was awarded his Master's degree at Northwestern Medical in 1999 for his work studying behavioral neuroscience in aged rodents. In 2005, at Baylor College of Medicine he received a PhD in Biochemistry for his work on proteins that regulate human telomeres. Postdoctoral research includes work at UC Berkeley on muscle stem cells and aging. Dr. O'Connor was a researcher and administrator at the SENS Research Foundation from 2010 through 2019 where he headed up the MitoSENS team from until 2016 when he took over oversight of SRF research as VP of Research with oversight over all intramural and extramural research. In 2019 he spun out a company, Cyclarity Therapeutics, to develop a drug targeting small toxic biomolecules that accumulate with age. CyclarityTx is located at the Buck Institute for Research on Aging.

Steve Horvath, Ph.D.

Altos Labs - Principal Investigator

Dr. Horvath is a Professor of Human Genetics and Biostatistics at the David Geffen School of Medicine, University of California, Los Angeles. Dr. Horvath’s research lies at the intersection of aging research, epidemiology, chronic diseases, epigenetics, genetics, and systems biology. He works on all aspects of biomarker development with a particular focus on genomic biomarkers of aging. He developed a highly accurate multi-tissue biomarker of aging known as the epigenetic clock. Dr. Horvath developed systems biologic approaches such as weighted gene co-expression network analysis which lend themselves for integrating gene genomic data sets. These methods have been used for a broad spectrum of age-related diseases including neurodegenerative diseases, cancer, cardiovascular disease. Dr. Horvath received a Ph.D. in Mathematics from the University of North Carolina, Chapel Hill in 1995 and a Doctorate of Science in Biostatistics from the Harvard School of Public Health in 2000

Aubrey de Grey, Ph.D.

LEV Foundation - President and CSO

Dr. Aubrey de Grey is the biomedical gerontologist who researched the idea for and founded SENS Research Foundation. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.

Nathan Cheng

Longevity Biotech Fellowship - Co-Executive Director

Nathan Cheng is the Program Director of the On Deck Longevity Biotech Fellowship, General Partner at Healthspan Capital, and founder of Longevity Marketcap, the most widely read newsletter on investing in longevity biotechnology. He is also the founder of Longevity List and the host of The Longevity Biotech Show podcast. Nathan obtained his Master’s degree in Physics from the University of Toronto. He was awarded both CGS-Masters and CGS-Doctoral graduate scholarships from the Natural Sciences and Engineering Research Council of Canada.

Eric Morgen, M.D.

BioAge Labs - COO and Co-Founder

Eric Morgen, MD, MPH, FRCPC, is Co-founder and COO at BioAge Labs, a clinical-stage biopharmaceutical company advancing a broad pipeline of therapeutics to treat and prevent age-related diseases and extend human healthspan and lifespan. BioAge’s computational platform is rooted in longitudinal ‘omics and clinical data spanning more than 40 years and provides a powerful approach to select drug targets that can improve the way we age. Eric’s oversees the company’s clinical, computational, and cohort-based activities.

Stephanie Dainow

Lifespan.io - Executive Director

Stephanie Dainow is Executive Director at Lifespan.io [Lifespan Extension Advocacy Foundation], a US-based non-profit advocacy organization committed to accelerating biomedical technologies that will increase healthy human lifespan. The organization is well-known for responsible journalism, research, funding mechanisms, education, and decentralized science initiatives. Stephanie is also a Business Mentor to UC Davis' Venture Catalyst and SOSV's IndieBio venture fund and accelerator, consulting deep tech startup founders on business development and strategy, fundraising, and executive leadership. In 2022, she was given the Rising Star award at the Dublin Longevity Summit in recognition of her work in the aging and longevity field. Previously, Stephanie was with Singularity University in Silicon Valley, working across their Innovation Consultancy, Tech Think Tank, University for the Future, and Impact-based Startup Incubator. She's worked for a global management consultancy as a Life Sciences Business Manager and served as Account Director for BioMarin Pharmaceutical. Her early career in NYC spanned global growth for Interpublic Group's media arm, celebrity and brand marketing, and commercial entertainment. Stephanie has volunteered around the world and previously held an Advisory Board position at a 501(c)(3) that inspires Harlem youth to pursue STEM careers. She is passionate about empowering leaders to think differently about emerging technologies, disruption, and the future of corporate business.

Chauncey St. John

Angel Giving - CEO and Founder

Founder/CEO of Angel Giving, Co-Founder Web3 Builders Alliance, former GE Global Program Manager. Angel Protocol is a community united by purpose, brought together by a passion to democratize access to opportunity while using Web3 as a force for good.

Yuri Deigin

YouthBio Therapeutics - Director and Co-founder

Yuri is a serial entrepreneur, an expert in drug development and venture investments in biotechnology and pharmaceuticals. Yuri brings almost a decade of drug discovery and development experience from his previous role in a biotech startup where he oversaw research and development of original medicines aimed at treating diseases like Alzheimer's and rheumatoid arthritis. Yuri has a track record of not only raising over $20 million for his previous ventures but also initiating and overseeing 4 clinical trials and several pre-clinical studies, including studies in transgenic mice. He also has experience in pharmaceutical product launch, promotion, manufacturing and supply chain management. Since 2013 Yuri also serves as a vice-president of the non-profit Foundation "Science for Life Extension" whose goal is the popularization of the fight against age-related diseases. To further this cause, Yuri frequently blogs, speaks, writes op-ed pieces, and participates in various TV and radio shows. Yuri holds a B.Sc. from the University of Toronto and an M.B.A. from Columbia Business School. Yuri is the CEO of biotech company Youthereum Genetics.

Michael Geer

Humanity - Co-founder

After mass consumer success building the largest dating site (Badoo) and consumer VPN (AnchorFree) in the world, Michael, motivated by seeing family members encounter tragic health outcomes, joined forces with his Co-Founder Peter Ward to collaborate with longevity scientists to bring predictive health monitoring and longevity interventions directly to consumers to increase their healthspans. Humanity is already slowing the aging of over one hundred thousand people.

Omar ElNaggar

Weavechain - CEO and Co-founder

Technologist focused on driving software products to improve the nature of work. Experience at a hedge fund established an obsession with the ROI of technology and effort. Shift to Enterprise software startup Sapho setup added in the ability to automate and streamline work. Driving acquisition by Citrix led to taking a product to global scale. And founding Weavechain setup a deep dive into how Web3 can make data more secure and more valuable, combining collaboration, monetization, and blockchain immutability and provenance.

Keith Comito

Lifespan.io - President and Co-founder

Keith Comito is a mathematician, computer programmer, and leading advocate for research aimed at extending healthy human lifespan. In addition to developing high-profile mobile applications such as HBO NOW and Disney+, he is an inventor of several DeSci and metaverse-adjacent technologies, such as that behind the GroupWatch feature of Disney+.  As president of Lifespan.io, he is a driving force towards overcoming age-related disease, participating in numerous speaking engagements around the world and working to produce high-impact media projects to inform and engage the public regarding this critical topic.  In the past he has created popular video games, musical applications, and biotechnology projects featured in Forbes and NPR - such as his work with the Brooklyn community lab Genspace, where he helped create games which allow players to direct the motion of microscopic organisms using galvanotaxis. Keith is also a practitioner of various martial arts, writer of music, and host of several science education and retro video game–themed YouTube channels.  He earned a B.S. in Mathematics, B.S. in Computer science, and M.S. in Applied Mathematics at Hofstra University, where his work included analysis of the LMNA protein.

Namir Khaliq

Protostellar Media - Head of Operations

Namir Khaliq is the founder of Protostellar Media, a production company designed specifically to help scientists tell stories about their work. The company provides the groundwork for scientists and science communicators to establish themselves as part of the creative process for film and television, with current partners including Daniel Kahneman, Nick Bostrom, Richard Dawkins, Helen Fisher, The Santa Fe Institute, and the Life Extension Advocacy Foundation. Prior to Protostellar, Namir worked in feature film and scripted television development at Imagine Entertainment, the multi-Academy and Emmy Award winning production company of director Ron Howard and producer Brian Grazer, where he helped develop films such as 13 Lives (Amazon), The Beanie Bubble (Apple), and Friday Night Lights (Universal), and television shows such as Filthy Rich (Fox), Genius (Nat Geo), and Under the Banner of Heaven (FX). He previously worked in film development, production, and sales at companies including Mosaic Media Group, Everyman Pictures, Funny or Die, and VMI Worldwide.

Kennedy Schaal

SingularityNet - Spin-Off CEO - Rejuve.bio

Accomplished biotechnology executive with strong leadership track record in applied genomic research and Artificial Intelligence at the frontier of longevity science. Multi-published author on the science of longevity and applied genomics trials. World leading expert on genomic selection and breeding for innovative Drosophila Methuselah Flies, which together with applied Artificial Intelligence solve for many of today’s pain points in longevity research, with potential for massive impact on health and lifespan of people across the planet. Experienced Laboratory Director and Chief Biologist with a demonstrated history of working in the biotechnology industry. Strong research professional skilled in evolutionary biology, genetics, and the study of aging related diseases. Also skilled in experiment design and execution, presentation, and public speaking.

Dylan Livingston

Alliance for Longevity Initiatives - President and Founder

Dylan helped to found the Alliance for Longevity Initiatives, a 501(c)(4) nonprofit organization focused on advocating for government-sponsored initiatives and policies to increase healthy human lifespan.

Ben Armstrong

Bitboy Crypto - Founder

Cryptocurrency enthusiast and content creator. Doing his part to spread adoption and move Bitcoin and cryptocurrencies into the mainstream.

Jelani Clark, Ph.D.

DeSci World - Executive Lead

A neuroimmunologist by training,with experience in the biotech industry which includes successfully developing an IPSC platform for the modeling of CNS disease states via the manipulation of human stem and non-stem cell culture lines as well as the designing and implementation of lineage and disease state characterization assays including genetic (qRT-PCR, Immunocytochemistry, Western Blot) and physiological (ELISA, JC10) markers. His responsibilities as a core at DeSciWorld, a project operating in the decentralized science (DeSci) space, include overseeing the generation of media content, business development, and coordinating business-to-business, business-to-science, and DAO-to-DAO relations.

Patrick Joyce, M.D.

ResearchHub - COO and Co-founder

M.D. and Co-Founder at ResearchHub, a tool for the open publication and discussion of scientific research.

Kenneth Bogner

Montana Senate - State Senator

Kenneth Bogner is an American politician from the state of Montana. He is a member of the Montana Senate, representing the 19th district.

Oliver Medvedik, Ph.D.

Lifespan.io - Vice President and Head of Research

Oliver Medvedik is presently the Director of the Kanbar Center for Biomedical Engineering at The Cooper Union, where he carries out research on improving gene targeting in mammalian cells, enzymatic oligonucleotide synthesis and other bioengineering projects with undergraduate and graduate students at the Albert Nerken School of Engineering. During the summers he also teaches a synthetic biology STEM course for high school students at The Cooper Union, as well as designing and teaching molecular and cell biology courses for undergraduates during the fall and spring semesters.  He is co-founder of the community biotechnology laboratory, Genspace, located in Brooklyn, where he continues to serve on its board of directors. A first of its kind, it is an open biotechnology laboratory that enables individuals, unaffiliated with any institution, to use the tools of biotechnology in a shared, co-working, biosafety level one laboratory space, on various biotech projects. He presently teaches CRISPR-Cas9 gene editing workshops that he has designed for the public at Genspace. He is also co-founder and vice-president of the non-profit organization Lifespan.io / LEAF (Lifespan Extension Advocacy Foundation), where he serves on the board of directors. LEAF has launched a crowd-funding platform for fiscally sponsoring research directed towards longevity and diseases of aging. He has worked as a biotechnology consultant at Sirtris Pharmaceuticals and has taught molecular and synthetic biology to hundreds of students while at Harvard University, The Cooper Union, School of Visual Arts, Genspace and NYU. He has also instructed six different undergraduate teams for the International Genetically Engineered Machines Competition (iGEM) from 2009-2015.  He continues to collaborate on bio-inspired projects with TerreformOne, a non-profit architecture group for smart city design, ecological planning and art, where he also serves as Director of Science. He was awarded a TED Fellowship in 2012.

Laura Minquini

AthenaDAO - Founder

Specialized in branding and business development, Laura launched and brought to market the first fashion-focused tech accessories, Case Scenario, achieving premium worldwide distribution, millions of dollars in sales, and became an Apple third party vendor within a year. Experienced in bringing new products to market and marketing strategy, Laura has a unique global vision and understanding of designed consumer experiences. I have collaborated with companies like Louis Vuitton, Apple, and Pantone.

Peter Fedichev, Ph.D.

GERO - CEO and Co-founder

Peter Fedichev is a scientist and biotech entrepreneur. His scientific background lies in the field of condensed matter physics, biophysics and bioinformatics. Peter earned M.S. in theoretical physics from the Moscow Institute of Physics and Technology and Ph.D. from the University of Amsterdam. He conducted research at Kurchatov Institute, one of the leading science government agencies in Russia, FOM Institute AMOLF (Netherlands), Moscow University of Physics and Technology, and the University of Innsbruck. To date, he has published over 70 papers in peer-reviewed journals covering his research on physics, biophysics and aging biology. Peter is a founder of Gero, a data-driven longevity startup focused on developing therapies that will strongly extend a healthy human lifespan.

Joanna Bensz

Longevity Center - Ceo and Founder

Joanna Bensz is a Co-founder and CEO at Longevity Institute, a non-profit organization providing an open knowledge platform for identifying, highlighting and supporting solutions to today's healthy longevity sector challenges and opportunities. The Longevity Institute is the first private institute in Poland in the field of healthy aging, healthy lifestyle and the use of the latest scientific achievements, artificial intelligence and blockchain technology in this sector. One of their missions is to create a bridge between business, academia, financial institutions and start-up companies in the area of healthy longevity and health preservation. The Longevity Institute brings together a global community of cross sector experts, organizations and entrepreneurs with an interest in healthy longevity, age science, preventive healthcare and longevity economy. Joanna has a significant experience in the management and business development of international companies from the industrial and technological sectors in Poland and the region of Central and Eastern Europe. She was associated with the American Chamber of Commerce in Poland for many years. Joanna has a master's degree in German philology and a diploma in international and strategic marketing at the Dublin Business School in Ireland. She is also a graduate of the AMP management program at the IESE Business School at the University of Navarra in Barcelona and Warsaw.

Morten Scheibye-Knudsen, Ph.D.

University of Copenhagen - Associate Professor and Group Leader

Aging is the largest risk factor for most diseases and damage to our genome is a likely cause of aging. My work focuses on exploring the physiological consequences of DNA damage and what we can do to intervene in genotoxic insults. My goal is to understand, modulate and perhaps treat aging and age related diseases.

Gary W. Arendash, Ph.D.

NeuroEM Therapeutics, Inc. - CSO and Co-founder

Co-Founder and Chief Scientific Office, NeuroEM Therapeutics, Inc. Formerly Research Professor at the University of South Florida (USF) and the Florida Alzheimer’s Disease Research Center where he initially investigated the effects of Transcranial Electromagnetic Treatment (TEMT) on brain pathology and cognitive function in Alzheimer’s model mice.

Wojciech Sierocki, M.D.

Data Lake - CEO and Co-founder

Wojciech is a medical doctor, humanitarian and serial entrepreneur. Forbes 25 under 25 and 30 under 30, he led a telemedicine startup in Kenya and built a digital patient's pathway solution for private healthcare. After spending a large portion of the pandemic working in an ER ward, Wojtek returned to his passion of working at the frontier of humanity's technological progress.

Brian Magierski

21 Impact Labs AG - CEO and Founder

Serial entrepreneur, co-founder and CEO/COO of multiple software startups, successfully raised multiple rounds of VC/PE capital, bought and sold businesses, including exit of $340m software startup to publicly traded company. Harvard MBA, Cornell BS, advisory board member to Entrepreneurship@Cornell, board member at Trinity Episcopal School and the Rise School of Austin, parent to child with Down syndrome

Kelsey Moody, Ph.D.

Ichor Life Sciences, Inc. - CEO

Dr. Kelsey Moody is a process-oriented biotechnology executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, He has successfully built Ichor Therapeutics from a living room start-up into a premier, vertically integrated contract research organization that focuses on pre-clinical research services for aging pathways. Proceeds from this work are used to self-fund R&D initiatives that constitute Ichor’s portfolio companies in enzyme therapy (Lysoclear, Inc.), small molecule drug discovery (Antoxerene, Inc.), and protein engineering (RecombiPure, Inc.). Kelsey has received graduate-level training in medicine, business, and laboratory research.

Fiona Miller

Quadrascope - Managing Partner

Fiona Miller is a Managing Partner at quadraScope Venture Fund. Prior to joining the longevity investment community, her focus was on wireless technologies, initially working as an electronics design engineer and R&D manager before going off on her own to launch new technology ventures. She was founder and CEO of octoScope, sold to Spirent Communications in 2021; Founder and CTO of Azimuth Systems, sold to Anritsu in 2016; and VP of Engineering at Scope Communications, sold to Hewlett-Packard (now Keysight) in 1998. Fiona holds 10 patents.

Michael Ringel, Ph.D.

Boston Consulting Group - Managing Director and Senior Patner

Michael Ringel is Boston Consulting Group's global leader for innovation analytics and research and product development, and is a core member of the firm’s Corporate Finance & Strategy practice.

Hans Keirstead, Ph.D.

Immunis Inc. - Chairman of the Board

Dr. Keirstead is an internationally renowned stem cell expert who has pioneered therapies for cancer, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. For over two decades, Dr. Keirstead has lead investigations on regenerative medicine. He spent 15-years as a full-tenured Professor of Anatomy and Neurobiology at UC Irvine, mentoring 100+ students, publishing 100+ manuscripts and receiving over 20 patents. He is currently the CEO of AIVITA Biomedical and the Chairman of Immunis, Inc., which investigates cellular secretomes as an immunomodulator for age-related disease.

Todd White

VitaDAO - Steward, Coordination Working Group

A seasoned business executive and early-stage investor, Todd has over 26 years of experience in start-up technology and biotech companies, where he has held C-level management roles and served as an executive advisor. His experience in corporate strategy, operations, and venture financing, combined with his passion for healthspan-focused science, has found him working at the intersection of the global decentralized science (“DeSci”) and cryptocurrency eco-systems-an area which has as its constituents, many longevity advocates. Currently, Todd serves as the Managing Director of the recently launched Vitality Healthspan Foundation, is an ODLB Fellow, and is Operations Steward for VitaDAO.

Reason .

Repair Biotechnologies - CEO

Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the Methuselah Foundation and SENS Research Foundation since the early 2000s. He is also the founder and writer of Fight Aging!, a noted news and commentary website in the biotechnology community. Prior to his involvement in the biotechnology industry, Reason was a consultant in the software industry. He holds Masters degrees in Astrophysics from the University of St. Andrews and Space Physics from Rice University.

J Robertson

Próspera - VP of Development

VP of Development at Próspera Global. Interested in governance, startup cities, and Ole Miss sports.

Maximilian Unfried, Ph.D.

National University of Singapore

Maximilian is a PhD student from the Kennedy Lab at the National University of Singapore Centre for Healthy Longevity, where he uses methodologies from AI and Complexity Science to investigate the ageing process. He holds a BSc in Integrated Life Science and a MSc in Complex Adaptive Systems.  Prior to joining the Kennedy Lab, he spent a few years in the startup industry as a Machine Learning Engineer, developing AI systems in the medical, financial and agricultural sector. He is a passionate Data Scientist and has research and hands-on experience in Machine Learning and Deep Learning in the domains of Natural Language Processing and Computer Vision.  He likes to share his knowledge of Artificial Intelligence in form of talks, seminars and panel discussions. He has been involved as an advisor for multinational corporations, investors and politicians with matters on the future of Artificial Intelligence, Crypto and Longevity.  The research of Maximilian is on the intersection of Ageing Biology, Artificial Intelligence and Complexity Science. He uses Generative Deep Neural Networks to generate novel molecules with health and lifespan extending properties, with a focus on brain health. To understand ageing on a more fundamental level, he uses a computational systems approach to model the intricate complex dynamics with the aim to decipher molecular mechanisms that impact aging. Maximilian ambition is to develop commercialisable health extending molecules that allow the general population to have a longer and healthier life.  His personal goal is to live a healthy and joyfully to a 120 years.

Mahdi Moqri, Ph.D.

Harvard Medical - Research Fellow in Aging Research

Research Fellow in Aging Research at Harvard (Gladyshev Lab, Genetics) and Stanford (Snyder Lab, Genetics). I am also leading the execute committee of the Biomarkers of Aging Consortium, to establish reliable biomarkers for longevity interventions. This year, I'm devoting 1 day/week to mentoring, advising, or consulting in longevity, omics biomarkers, computational biology, and bioinformatics. My service to nonprofits is free of charge.  * Longevity: Methuselah Foundations, Longevity Prize, Amaranth Prize, VitaDAO, Longevity Biotech Fellowship * Students: Tara Murty (Stanford), Bryce Tiglon (Stanford), Shulin Mao (Harvard)  * Selected longevity startups

Azeem Khan

Gitcoin - Head of Impact

Head of Impact of the public goods funding DAO Gitcoin, accomplished entrepreneur, and member of the World Economic Forum’s crypto sustainability coalition.

Natasha Vita-More, Ph.D.

Humanity Plus - Executive Director

Dr. Natasha Vita-More catalyzed transhumanism as a world movement, with a focus on a more humane humanity, longevity, and ethical use of advancing technologies. She developed the first whole-body prosthetic prototype for the future. She established a scientific discovery in cryobiology on long-term memory of the simple animal C. elegans. These three specific accomplishments are original works by Natasha and have been highly recognized in helping to establish seminal achievements in three different fields: philosophy, design, and science.  Natasha's innovations have introduced new ways of thinking about the science, technology, and social implications on humanity and our future. She received international recognition for designing the first whole-body prototype combining AI, nanorobotics, and biotech. She is featured in numerous magazines and dozens of televised documentaries on the future. including Special Recognition at Women in Video. Currently, Dr. Vita-More is Ret. Professor and Department Chair at UAT. She continues to appear in documentaries on the future and speak at conferences about human potential, adapting to change, and the most up-to-date technologies that are affecting our world. Natasha is published in numerous books: Oxford Handbook of Human Symbolic Evolution, AI Society, Anticipating 2025, Intelligence Unbound, Human InBetween, Modified: Living as a Cyborg, Homo Kybernetics, and her own book The Transhumanist Reader is published by the renown Wiley Blackwell. Her essays are included in academic journals: Rejuvenation Research, Metaverse Creativity, Technoetic Arts - A Journal of speculative Research, New Realities: Being Syncretic, Beyond Darwin, and D’ARS.. Wired magazine called Natasha an "early adopter of revolutionary ideas" and Village Voice claimed she is "a role model for superlongevity". Natasha authored the Transhuman Manifesto (1983), co-founded the transhumanist movement (1991), innovated the seminal whole-body prosthetic prototype (1996), and performed a scientific breakthrough on vitrification and long-term memory of simple animals (2015). "Natasha is the original trailblazer of Transhumanism." (FM Esfandiary (2030). Vita-More has exhibited at the London Contemporary Art Museum, Niet Normaal, and the Moscow Film Festival. She is most known for having designed the pioneering whole-body prototype and the networked identity “Primo Posthuman”. With a background as an immersive designer in multi-media, her work focuses on science, technology, and philosophy of human futures.

Eleanor Davies

VitaDAO - Steward, Longevity Dealflow Working Group

Core team member at VitaDAO and LabDAO, and decentralized Science operator with a background in fund ops, and consulting in healthcare and biotech policy and regulation.

Deborah Duong, Ph.D.

Rejuve- CTO

https://www.linkedin.com/in/deborah-duong-02a0aa49/